Kevin David Simpson

Title: Kevin David Simpson: Innovator in Assay Technology

Introduction

Kevin David Simpson is a notable inventor based in New Orleans, LA (US). He has made significant contributions to the field of assay technology, particularly in the detection of antibodies. His innovative approach has led to the development of a unique patent that addresses important medical testing needs.

Latest Patents

Kevin David Simpson holds a patent for an "Assay for anti-polyvinyl alcohol antibodies." This patent describes a method for detecting antipolyvinyl alcohol (anti-PVAL) antibodies in test samples, such as serum. The method involves combining a sample to be tested for an anti-PVAL antibody with polyvinyl alcohol (PVAL) to form a binary complex. This complex is then reacted with an indicator reagent to form a labeled ternary complex, which can be detected in the sample. The patent also includes kits for performing the test, showcasing the practical applications of his invention.

Career Highlights

Kevin is currently associated with Autoimmune Technologies, LLC, where he continues to advance his research and development efforts. His work focuses on improving diagnostic methods that can enhance patient care and treatment outcomes.

Collaborations

Kevin collaborates with Russell B. Wilson, leveraging their combined expertise to drive innovation in their field. Their partnership exemplifies the importance of teamwork in advancing scientific research and technology.

Conclusion

Kevin David Simpson's contributions to assay technology highlight his role as an innovator in the medical field. His patent for detecting anti-PVAL antibodies represents a significant advancement in diagnostic methods. Through his work at Autoimmune Technologies, LLC, he continues to make strides in improving healthcare solutions.